West Pharmaceutical Services, Inc. (WST): Price and Financial Metrics


West Pharmaceutical Services, Inc. (WST): $421.19

-1.04 (-0.25%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

WST POWR Grades


  • Sentiment is the dimension where WST ranks best; there it ranks ahead of 95.8% of US stocks.
  • WST's strongest trending metric is Quality; it's been moving down over the last 52 weeks.
  • WST's current lowest rank is in the Momentum metric (where it is better than 10.92% of US stocks).

WST Stock Summary

  • West Pharmaceutical Services Inc's market capitalization of $31,236,189,904 is ahead of 90.96% of US-listed equities.
  • WST's went public 33.82 years ago, making it older than 89.21% of listed US stocks we're tracking.
  • Price to trailing twelve month operating cash flow for WST is currently 62.42, higher than 92.64% of US stocks with positive operating cash flow.
  • If you're looking for stocks that are quantitatively similar to West Pharmaceutical Services Inc, a group of peers worth examining would be ALGN, CE, CSGP, LOGI, and ICUI.
  • Visit WST's SEC page to see the company's official filings. To visit the company's web site, go to www.westpharma.com.

WST Valuation Summary

  • In comparison to the median Healthcare stock, WST's price/sales ratio is 16.3% higher, now standing at 13.2.
  • WST's price/earnings ratio has moved NA NA over the prior 243 months.
  • Over the past 243 months, WST's price/earnings ratio has gone NA NA.

Below are key valuation metrics over time for WST.

Stock Date P/S P/B P/E EV/EBIT
WST 2021-08-31 13.2 16.4 64.3 52.6
WST 2021-08-30 13.2 16.4 64.4 52.7
WST 2021-08-27 13.1 16.3 63.7 52.1
WST 2021-08-26 13.1 16.3 63.6 52.1
WST 2021-08-25 13.0 16.2 63.3 51.8
WST 2021-08-24 13.1 16.2 63.5 52.0

WST Growth Metrics

  • Its 5 year net income to common stockholders growth rate is now at 172.59%.
  • The 5 year price growth rate now stands at 210.82%.
  • Its year over year net cashflow from operations growth rate is now at 33.82%.
WST's revenue has moved up $1,122,700,000 over the prior 67 months.

The table below shows WST's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 2,522.5 500.4 519.2
2021-03-31 2,326.1 504.1 423.1
2020-12-31 2,146.9 472.5 346.2
2020-09-30 2,037.3 430.2 311.7
2020-06-30 1,945.4 419.7 285.7
2020-03-31 1,887.9 376.7 260.6

WST's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • WST has a Quality Grade of C, ranking ahead of 73.9% of graded US stocks.
  • WST's asset turnover comes in at 0.913 -- ranking 8th of 22 Rubber and Plastic Products stocks.
  • TUP, MYE, and ENTG are the stocks whose asset turnover ratios are most correlated with WST.

The table below shows WST's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.913 0.394 0.328
2021-03-31 0.885 0.375 0.281
2020-12-31 0.857 0.358 0.238
2020-09-30 0.852 0.348 0.220
2020-06-30 0.850 0.341 0.206
2020-03-31 0.850 0.332 0.195

WST Price Target

For more insight on analysts targets of WST, see our WST price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $436.00 Average Broker Recommendation 1.5 (Moderate Buy)

WST Stock Price Chart Interactive Chart >

Price chart for WST

WST Price/Volume Stats

Current price $421.19 52-week high $475.35
Prev. close $422.23 52-week low $253.85
Day low $419.17 Volume 385,600
Day high $424.80 Avg. volume 394,037
50-day MA $436.69 Dividend yield 0.17%
200-day MA $353.32 Market Cap 31.16B

West Pharmaceutical Services, Inc. (WST) Company Bio


West Pharmaceutical Services develops, manufactures, and sells components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare, and consumer products industries. The company operates through two segments, Pharmaceutical Packaging Systems and Pharmaceutical Delivery Systems. The company was founded in 1923 and is based in Exton, Pennsylvania.


WST Latest News Stream


Event/Time News Detail
Loading, please wait...

WST Latest Social Stream


Loading social stream, please wait...

View Full WST Social Stream

Latest WST News From Around the Web

Below are the latest news stories about West Pharmaceutical Services Inc that investors may wish to consider to help them evaluate WST as an investment opportunity.

West Introduces DeltaCube Modeling Platform and NovaGuard® SA Pro Safety System for 0.5 mL Standard Glass Syringes at Interphex

EXTON, Pa., Oct. 19, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will unveil its DeltaCube Modeling Platform as well as the new NovaGuard® SA Pro Safety System for

PR Newswire | October 19, 2021

West Introduces DeltaCube™ Modeling Platform and NovaGuard® SA Pro Safety System for 0.5 mL Standard Glass Syringes at Interphex

West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will unveil its DeltaCube™ Modeling Platform as well as the new NovaGuard® SA Pro Safety System for ISO 0.5mL Standard Glass Syringes at Interphex, taking place October 19 to 21 in New York, New York.

Yahoo | October 19, 2021

Where Do Hedge Funds Stand On West Pharmaceutical Services Inc. (WST)?

We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, smart money investors have to conduct complex analyses, spend many resources and use tools that are not always […]

Yahoo | October 18, 2021

West to Host Third-Quarter 2021 Conference Call

West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter 2021 financial results before the market opens on Thursday, October 28, 2021, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call, please dial 877-930-8295 (U.S.) or 253-336-8738 (International). The conference ID is 5587559.

Yahoo | October 14, 2021

Why the Earnings Surprise Streak Could Continue for West Pharmaceutical (WST)

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? West Pharmaceutical Services (WST), which belongs to the Zacks Medical - Dental Supplies industry, could be a grea

iShook Finance | October 12, 2021

Read More 'WST' Stories Here

WST Price Returns

1-mo -6.23%
3-mo 10.53%
6-mo 30.19%
1-year 51.07%
3-year 273.39%
5-year 500.38%
YTD 48.90%
2020 89.05%
2019 54.13%
2018 -0.08%
2017 17.02%
2016 41.87%

WST Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full WST Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 7.1103 seconds.